logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Péter Lakatos

Medical University of Vienna
H指数:46
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial
JOURNAL OF BONE AND MINERAL RESEARCH
IF5.9
2018-01-1277
OAAI
Geusens, Piet; Marin, Fernando; Kendler, David L.; Russo, Luis A.; Zerbini, Cristiano A. F.; Minisola, Salvatore; Body, Jean Jacques; Lespessailles, Eric; Greenspan, Susan L.; Bagur, Alicia; Stepan, Jan J.; Lakatos, Peter; Casado, Enrique; Moericke, Ruediger; Lopez-Romero, Pedro; Fahrleitner-Pammer, Astrid
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

Romosozumab (硬骨素单克隆抗体) 与特立帕肽在绝经后骨质疏松症妇女中从口服双膦酸盐治疗过渡: 一项随机，开放标签，3期试验

LANCET
IF88.5
2017-09-01229
PREAI
Langdahl, Bente L.; Libanati, Cesar; Crittenden, Daria B.; Bolognese, Michael A.; Brown, Jacques P.; Daizadeh, Nadia S.; Dokoupilova, Eva; Engelke, Klaus; Finkelstein, Joel S.; Genant, Harry K.; Goemaere, Stefan; Hyldstrup, Lars; Jodar-Gimeno, Esteban; Keaveny, Tony M.; Kendler, David; Lakatos, Peter; Maddox, Judy; Malouf, Jorge; Massari, Fabio E.; Fernando Molina, Jose; Rosa Ulla, Maria; Grauer, Andreas
SUPERIOR GAINS IN BONE MINERAL DENSITY AND ESTIMATED STRENGTH AT THE HIP FOR ROMOSOZUMAB COMPARED WITH TERIPARATIDE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS TRANSITIONING FROM BISPHOSPHONATE THERAPY: RESULTS OF THE PHASE 3 OPEN-LABEL STRUCTURE STUDY
ANNALS OF THE RHEUMATIC DISEASES
IF20.6
2016-06-010
PREAI
Langdahl, B.; Libanati, C.; Crittenden, D.; Bolognese, M.; Brown, J.; Daizadeh, N.; Dokoupilova, E.; Engelke, K.; Finkelstein, J.; Genant, H.; Goemaere, S.; Hyldstrup, L.; Jodar-Gimeno, E.; Keaveny, T.; Kendler, D.; Lakatos, P.; Maddox, J.; Malouf, J.; Massari, F.; Molina, J.; Ulla, M.; Grauer, A.
The Effect of 6 Versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)

唑来膦酸治疗骨质疏松症6年和9年的效果: HORIZON-枢轴骨折试验 (PFT) 的随机第二次扩展

JOURNAL OF BONE AND MINERAL RESEARCH
IF5.9
2014-12-26194
OAAI
Black, Dennis M.; Reid, Ian R.; Cauley, Jane A.; Cosman, Felicia; Leung, Ping Chung; Lakatos, Peter; Lippuner, Kurt; Cummings, Steven R.; Hue, Trisha F.; Mukhopadhyay, Amitava; Tan, Monique; Aftring, R. Paul; Eastell, Richard

研究方向

暂未获取到该数据
C
Charles M. Schroeder
H 指数:68论文数:378被引数:2.4万
D
Daniel C. Javitt
H 指数:111论文数:464被引数:4.0万
M
Monica N. O’Connell
H 指数:17论文数:32被引数:2,470
A
Annamaria Barczak
H 指数:15论文数:29被引数:1,599
D
David L. Kendler
H 指数:68论文数:252被引数:2.1万
T
Tammy McGinnis
H 指数:13论文数:24被引数:974
A
Arnaud Falchier
H 指数:21论文数:59被引数:5,390
A
Antı́gona Martı́nez
H 指数:45论文数:132被引数:1.0万
S
Salvatore Minisola
H 指数:72论文数:516被引数:1.6万
B
Bente Langdahl
H 指数:67论文数:425被引数:1.9万